Anti-Covid medicine successfully produced

Myanmar FDA-recommended Paclovid (oral drug) for Covid-19.

Anti-Covid medicine will be produced when an order is received from the Ministry of Health, according to the Myanma Pharmaceutical Industry, Ministry of Industry.
Myanma Pharmaceutical Industry produces various kinds of medicines, including Covid vaccines, for the Ministry of Health and has been producing K55 billion worth of COVID vaccines since the outbreak of the pandemic.
Paclovid (Nirmatrelvir 150 mg + Ritonavir 100 mg) is a kind of Covid drug.
A packet of Paclovid (30 capsules) costs K250,000 and is available only on prescription, according to Pacific Medical Industries.
Pacific Medical Industries Ltd successfully produced the medicine with Myanmar FDA recommendation number (2308ND 012). The medicine is also recommended by WHO, US FDA, UK MHRA, Korean FDA, and Singapore FDA. — TWA/GNLM

Share this post
Hot News
Hot News
Union Information Minister inspects Pyinmana-Thabyay Taung MRTV retransmission station
NSA Union Minister hosts dinner for BIMSTEC delegates
DPM MoFA Union Minister receives Russian Ambassador
Myanmar attends India-ASEAN Trade Conference 2024 in India
NSA & Union Minister receives BIMSTEC national security chiefs
Myanmar calls for collaboration to ensure food, energy security during 4th BIMSTEC National Security Chiefs’ Meeting
SAC Vice-Chair Deputy PM Vice-Senior General Soe Win receives Russian Ambassador to Myanmar
Myanmar, Sri Lanka to promote sector-wise cooperation
E-government initiative key to advancing digital economy
‘With Rain’ displays at Artistic Space art gallery